News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
831,741 Results
Type
Article (85619)
Company Profile (744)
Press Release (745378)
Section
Business (232262)
Career Advice (4106)
Deals (39645)
Drug Delivery (116)
Drug Development (90658)
Employer Resources (194)
FDA (17977)
Job Trends (17274)
News (395594)
Policy (39620)
Tag
Academia (2975)
Alliances (56461)
Alzheimer's disease (1337)
Approvals (17885)
Artificial intelligence (158)
Bankruptcy (394)
Best Places to Work (12521)
Biotechnology (509)
Breast cancer (131)
Cancer (1180)
Cardiovascular disease (109)
Career advice (3513)
Cell therapy (271)
Clinical research (71547)
Collaboration (420)
Compensation (207)
COVID-19 (2803)
C-suite (106)
Data (1159)
Diabetes (168)
Diagnostics (6683)
Earnings (94756)
Employer resources (167)
Events (126812)
Executive appointments (328)
FDA (18547)
Funding (379)
Gene therapy (204)
GLP-1 (697)
Government (5048)
Healthcare (20719)
Infectious disease (2897)
Inflammatory bowel disease (121)
Interviews (807)
IPO (17592)
Job creations (5179)
Job search strategy (2855)
Layoffs (489)
Legal (10044)
Lung cancer (190)
Manufacturing (202)
Medical device (14414)
Medtech (14419)
Mergers & acquisitions (22100)
Metabolic disorders (473)
Neuroscience (1644)
NextGen Class of 2024 (7657)
Non-profit (5065)
Northern California (1521)
Obesity (271)
Opinion (244)
Patents (112)
People (64187)
Pharmaceutical (147)
Phase I (22020)
Phase II (31074)
Phase III (23420)
Pipeline (470)
Postmarket research (3539)
Preclinical (9960)
Radiopharmaceuticals (259)
Rare diseases (246)
Real estate (7373)
Regulatory (25965)
Research institute (2642)
Resumes & cover letters (648)
Southern California (1346)
Startups (4276)
United States (14641)
Vaccines (652)
Weight loss (221)
Date
Today (146)
Last 7 days (753)
Last 30 days (4013)
Last 365 days (38560)
2024 (35409)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Arizona (228)
Asia (49347)
Australia (8696)
California (3539)
Canada (1313)
China (264)
Colorado (158)
Connecticut (172)
Europe (113030)
Florida (475)
Georgia (127)
Illinois (418)
Indiana (216)
Kansas (103)
Maryland (631)
Massachusetts (2862)
Michigan (178)
Minnesota (299)
New Jersey (1007)
New York (1004)
North Carolina (843)
Northern California (1521)
Ohio (149)
Pennsylvania (870)
South America (1647)
Southern California (1346)
Texas (509)
Washington State (402)
There are 831,741 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Gene therapy
Patient Death in Rett Syndrome Trial Forces Neurogene to Drop High-Dose Arm
Despite the death, the FDA has allowed Neurogene to forge ahead with the Phase I/II Rett syndrome trial, but using only the lower 1E15 vg dose of its investigational gene therapy NGN-401.
November 22, 2024
·
2 min read
·
Tristan Manalac
Adcomms
AstraZeneca Fends Off Adcomm’s Safety Concerns on Andexxa, Axes Mid-Stage Opioid Use Disorder Drug
The pharma is seeking full approval for its anticoagulation reversal drug Andexxa, which the FDA granted accelerated approval in 2018 for patients who had been treated with apixaban or rivaroxaban.
November 22, 2024
·
3 min read
·
Tristan Manalac
Drug shortages
FDA Still Undecided About Shortage Status of Lilly’s Tirzepatide
Pending the FDA’s decision, compounding pharmacies will remain free to make and market versions of the blockbuster weight-loss therapy.
November 22, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Orion Research Foundation grants EUR 1,109,000 for research in 2025
November 22, 2024
·
4 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces IRB Approval for Phase I Clinical Trial
November 22, 2024
·
4 min read
Press Releases
FDA Granted Orphan Drug Designation of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs, for Treatment of Neuroendocrine Cancer
November 22, 2024
·
5 min read
Press Releases
Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 22, 2024
·
9 min read
Press Releases
HUTCHMED Announces Launch by Takeda of FRUZAQLA® (fruquintinib) in Japan
November 22, 2024
·
13 min read
Press Releases
Zymeworks Announces Participation in Upcoming Investor Conferences - November 21, 2024
November 22, 2024
·
3 min read
Press Releases
TearSolutions, Inc. Secures $3M Series B Funding
November 22, 2024
·
1 min read
1 of 83,175
Next
